WO2009117573A1 - Moving a small object in a direction - Google Patents
Moving a small object in a direction Download PDFInfo
- Publication number
- WO2009117573A1 WO2009117573A1 PCT/US2009/037661 US2009037661W WO2009117573A1 WO 2009117573 A1 WO2009117573 A1 WO 2009117573A1 US 2009037661 W US2009037661 W US 2009037661W WO 2009117573 A1 WO2009117573 A1 WO 2009117573A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- field
- force
- properties
- external influence
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Definitions
- a property 18 that makes an object susceptible to an external force is not inherent to the object, but instead is imparted to it.
- a charge can be imparted to a denatured protein by attaching negatively charged SDS molecules to it. Electrophoresis can then be performed by applying an electric field.
Abstract
For directional motion of a small object, a combination of at least two different properties is imparted to the object. At least one of the properties being responsive to an external influence to produce a force or torque acting on the object. At least another of the properties is responsive to the force or torque to cause a directional motion of the object.
Description
Moving a Small Object in a Direction
Background
This application has the benefit of the filing date of United States provisional application 61/038,573, filed March 21, 2008, and incorporated in its entirety here by reference.
United States patent application 12/103,281, filed April 15, 2008, is incorporated in its entirety here by reference.
United States provisional application 60/987,674, filed November 13, 2007, is incorporated in its entirety here by reference.
This description relates to moving a small object in a direction.
Small objects can be moved in specific directions by applying an external force or torque.
In some cases, the external force acts on a property of the object that is inherent to the object, renders the object susceptible to the force, and differs from a property of the medium in which the object is to be moved. For example, as shown in figure 1, in dielectrophoresis, an oscillating electric field (the external force 10) is applied to a cell (the object 12). The cell has a value of dielectric constant (a property 14) that is natural (inherent to the cell), makes the cell susceptible to the force, and is different from the value of dielectric constant of the fluid (the medium 16) around it.
In some cases, a property 18 that makes an object susceptible to an external force is not inherent to the object, but instead is imparted to it. For example, a charge (the property) can be imparted to a denatured protein by attaching negatively charged SDS molecules to it. Electrophoresis can then be performed by applying an electric field.
In some cases, for example a chiral molecule 20 as shown in figure 2, the object can be moved in a direction 22 by applying a rotating electric field 24 (the external influence). The rotating field acts on an electric dipole moment 26 of the molecule (the dipole moment being a first inherent property of the chiral molecule), causing the molecule to rotate. The chirality 28 of the molecule (its chirality being a second, inherent property)
translates the molecule's rotation 30 into motion in a direction 22. The direction 22 depends on the molecule's handedness (i.e., its chirality).
Summary
In general, in an aspect, for directional motion of a small object, a combination of at least two different properties is imparted to the object, at least one of the properties being responsiveness to an external influence to produce a force or torque acting on the object, at least another of the properties being responsiveness to the force or torque to cause a directional motion of the object.
Implementations may include one or more of the following features. Prior to the combination of the at least two properties being imparted to the object, no directional motion of the object is produced in response to the external influence. Prior to the combination of the at least two properties being imparted to the object, any directional motion of the object in response to the external influence is less than after the imparting. Neither of the properties is inherent in the object.
The object includes a cell, for example, a cell that is abnormal, dead, diseased, or drugged or exposed to other chemicals. The object includes a virus. The object includes, for example, a bacterium, a molecule, a biomolecule, a protein (which has, for example, a post-translational modification), a peptide, an enzyme, a DNA or RNA molecule, which may include an epimer, a polymer, a bead, a nanoparticle, an organelle, a liposome, a vesicle, a biomolecular aggregate, a molecular aggregate, or a spore.
The imparting includes attaching at least one other object, such as an antibody. The imparting includes adding another object. The other object includes a transfected gene. The imparting includes removing a p#rt of the object. The imparting includes causing a reaction on the object. The reaction, for example, is molecular, cellular, or chemical.
The external influence includes a force field, such as electric, magnetic, or gravitational. The gravitational field is centrifugal. The field includes a pressure field or an acoustic field. The force field is static, oscillating, or rotating. The external influence includes a reaction. The reaction is chemical, such as rotatory, molecular, or cellular. The external
influence includes a kinetic force, such as electroosmotic, electrophoretic, or one based on dielectrophoretic, optophoretic, or thermophoretic. The external influence includes a gradient, such as a chemical gradient or a field gradient. The other property includes chirality.
One of the properties may be imparted in the form of a dipole, such as an electric dipole or a magnetic dipole. The external influence may be a rotating electric field or a rotating magnetic field.
These and other aspects and features, and combinations of them, may be expressed as methods, apparatus, systems, means for performing functions, program products, and in other ways.
Other advantages and features will become apparent from the following description and from the claims.
Description
Figures 1, 2, 3, and 4 are schematic views of objects and external influences.
As shown in figure 3, a small object 40 can be moved in a direction 42 by (for example) an external force or torque 44 that operates on the object by means of at least two properties of the object (at least two of which 46, 48 are not inherent but have been imparted to the object). The motion in direction 42 occurs only if the object has both of the imparted properties, like an AND-logic gate, the output of which is 1 (corresponding to directional motion) only if the two inputs (the imparted properties), both have a value 1 (i.e., are present). There can be more than two imparted properties, and the object can also have one or more inherent properties.
For example, as shown in figure 3, assume that a biological sample 48 includes two different types of cells, one population of target cells 50 (TCs) and a second population of non-target cells 52 (NTCs), and the goal is to obtain an enriched population of TCs by moving 49 TCs from the sample and leaving NTCs behind.
As shown in figure 4, assume that we have supplies of (a) two antibodies (AbI and Ab2) that both have a stronger affinity to TCs than to NTCs, e.g., they preferentially bind to TCs and much less so to NTCs, (b) magnetic beads 54 that are super-paramagnetic, i.e., they exhibit magnetism (or they acquire a magnetic dipole moment) in the presence of a magnetic field, and (c) small objects 56 (e.g., ~l-10μm diameter, or .1-lμm diameter), either manufactured or natural that have a certain chirality (i.e., right-handed or left- handed, so let's assume all left-handed in this case). We sometimes call the small objects 56 propellers.
As shown in figure 4, we attach each AbI to a magnetic bead to form one complex 63, and each Ab2 to an artificial propeller 56 to form a complex 65, and we put both complexes (either sequentially or simultaneously) into the sample 48 that contains both TCs and NTCs. (In figure 4, we have only shown a single TC and a single NTC. Each AbI -magnetic bead complex 63 will attach to a TC in a specific manner with a relatively higher probability or to an NTC in a non-specific manner with a relatively lower probability. For simplicity of discussion, assume that the AbI -magnetic bead complexes will only bind to TCs and that the non-specific binding to NTCs is negligible.
Similarly, assume for simplicity that the Ab2-propeller complex 65 binds only to TCs (and not to NTCs).
When an AbI -magnetic bead complex binds to a TC, the magnetic bead will impart a magnetic dipole to the TC; an Ab2-propeller complex, in turn, will impart chirality to the TC.
We then apply a rotating magnetic field 66 to the sample, causing all magnetic beads, whether bound to TCs or not, to rotate with the magnetic field.
Any magnetic bead that is not bound to a cell or any complex of a bead bound to a cell that does not also have a propeller bound to it will not have any chirality, and therefore, will not move in a particular direction, in other words, it will not experience any directional motion.
Conversely, a propeller that is not bound to a cell or any complex of a propeller that is bound to a cell that does not also have a magnetic bead bound to it, will not have any magnetism, and the rotating magnetic field will have no effect on it. Even though the complex has chirality, it lacks magnetism to convert the external influence (the rotating magnetic field, in this case) into a force or a torque to cause it to rotate (and in turn be moved in a direction).
Only a cell 78 that has both a magnetic bead and a propeller attached to it (using AbI and Ab2, respectively, in this example) will rotate in response to a rotating magnetic field, and move in a direction 79 as the rotation is converted into directional motion (as a result of the chirality imparted to the cell by the propeller). Additional information about the use of rotation and chirality for propeller motion can be found in United States patent application 12/103,281, filed April 15, 2008, and incorporated in its entirety here by reference.
By imparting two properties, e.g., magnetism and chirality, that are not inherent to a small object (e.g., a cell), e.g. by attaching two other objects (one with magnetism, the other with chirality), an external influence (e.g., a rotating magnetic field) can be converted into a torque on the cell to rotate it and the rotation be used to move the cell in a particular direction (that is determined by the handedness of the propeller). In this example, both magnetism and chirality are required to generate the directional motion; if one is missing, there's none (without magnetism, the cell does not rotate, and without chirality, it is not propelled).
Using this combination of properties and an external influence, for example, target cells can propel themselves to a specific location in the container (using the specific binding of antibodies appropriate for those cells), leaving the non-target cells behind. Because both antibodies are selected to be ones that bind to the target cell and not to the non-target cell, the enrichment factor can be greatly enhanced. Furthermore, losses due to harsh and the use of possibly multiple extraction steps can be avoided, and the yield of such an enrichment process can be high. Yield loss due to de-bulking, for example, can be reduced.
Other examples are also within the scope of the claims.
The object need not be a cell. It could be a virus, bacteria, molecule, biomolecule, protein, peptide, enzyme, DNA, RNA, small molecule, polymer, bead, nanoparticle, organelles, liposome, vesicle, biomolecular aggregate, molecular aggregate, or spore, or any other small particle or object.
The cells may be modified to be abnormal, dead, diseased, and/or drugged; the proteins may have certain PTMs (post-translational modifications, e.g., glycosylated, phosphorylated); DNA and/or RNA molecules may be epimers.
The properties can be imparted to the objects in a wide variety of different ways. For example, an object (e.g., an antibody or a transfected gene) can be attached to or added to the target object. A portion of the target object can be removed. A reaction can be caused on the object (e.g., chemical, molecular or cellular) to change one of its properties.
The external influence may be: a field (electric, magnetic, electromagnetic, gravitational/centrifugal, pressure/acoustic/ultrasound), a reaction (e.g. chemical/rotatory chemistry, molecular, cellular), a kinetic force (e.g. electroosmotic, electrophoretic, dielectrophoretic, optophoretic, thermophoretic), or a gradient (e.g. chemical, field).
The property of the object to convert the external influence into a force or torque on the object may be a property that interacts with the external influence. For example, the property may be a permanent or induced electric dipole moment that interacts with an electric field; a permanent or induced magnetic dipole moment that interacts with a magnetic field; permittivity or permeability with respect to an electromagnetic field; mass (or buoyancy) with respect to a gravitational field; and so on for other external influences, including the ones mentioned above.
The second property to convert the force or torque on the object into directional motion of the object may be chirality, as explained in the examples, or other properties that produce directional motion.
We have used the word inherent to refer, for example, to a property that exists in an object in its naturally occurring form, or in the object in a form in which it is initially manufactured or altered or contemplated.
In some cases, the two properties can be imparted to the target object by a single action or a single other object. For example, the propelling property and the force receiving property can be embodied in a single object which is then attached to the target object.
In some cases, the object may have the two properties and the effect of the two properties for purposes of causing directional is enhanced by imparting the two properties again or in greater amount or in a second version, for example, to the object.
Claims
1. A method for use in directional motion of a small object, the method comprising,
imparting to the object a combination of at least two different properties,
at least one of the properties being responsive to an external influence to produce a force or torque acting on the object,
at least another of the properties being responsive to the force or torque to enhance the directional motion of the object.
2. The method of claim 1 in which, prior to the combination of the at least two properties being imparted to the object, there is no directional motion of the object in response to the external influence.
3. The method of claim 1 in which, prior to the combination of the at least two properties being imparted to the object, the directional motion of the object in response to the external influence is less than after the imparting.
4. The method of claim 1 in which neither of the properties is inherent in the object.
5. The method of claim 1 in which the object comprises a cell.
6. The method of claim 5 in which the cell is abnormal.
7. The method of claim 5 in which the cell is dead.
8. The method of claim 5 in which the cell is diseased.
9. The method of claim 5 in which the cell is drugged or exposed to other chemicals.
10. The method of claim 1 in which the object comprises a virus.
11. The method of claim 1 in which the object comprises a bacterium.
12. The method of claim 1 in which the object comprises a molecule.
13. The method of claim 1 in which the object comprises a biomolecule.
14. The method of claim 1 in which the object comprises a protein.
15. The method of claim 14 in which the protein has a post-translational modification.
16. The method of claim 1 in which the object comprises a peptide.
17. The method of claim 1 in which the object comprises an enzyme.
18. The method of claim 1 in which the object comprises a DNA molecule.
19. The method of claim 18 in which the DNA molecule comprises an epimer.
20. The method of claim 1 in which the object comprises an RNA molecule.
21. The method of claim 20 in which the RNA molecule comprises an epimer.
22. The method of claim 1 in which the object comprises a polymer.
23. The method of claim 1 in which the object comprises a bead.
24. The method of claim 1 in which the object comprises a nanoparticle.
25. The method of claim 1 in which the object comprises an organelle.
26. The method of claim 1 in which the object comprises a liposome.
27. The method of claim 1 in which the object is a vesicle.
28. The method of claim 1 in which the object comprises a biomolecular aggregate.
29. The method of claim 1 in which the object comprises a molecular aggregate.
30. The method of claim 1 in which the object comprises a spore.
31. The method of claim 1 in which the imparting comprises attaching at least one other object.
32. The method of claim 31 in which the other object comprises an antibody.
33. The method of claim 1 in which the imparting comprises adding another object.
34. The method of claim 33 in which the other object comprises a transfected gene.
35. The method of claim 1 in which the imparting comprises removing a part of the object.
36. The method of claim 1 in which the imparting comprises causing a reaction on the object.
37. The method of claim 36 in which the reaction is molecular.
38. The method of claim 36 in which the reaction is cellular.
39. The method of claim 36 in which the reaction is chemical.
40. The method of claim 1 in which the external influence comprises a force field.
41. The method of claim 40 in which the force field is static.
42. The method of claim 40 in which the force field is oscillating.
43. The method of claim 40 in which the force field is rotating.
44. The method of claim 40 in which the field comprises an electric field.
45. The method of claim 40 in which the field comprises a magnetic field.
46. The method of claim 40 in which the field comprises a gravitational field.
47. The method of claim 46 in which the gravitational field is centrifugal.
48. The method of claim 40 in which the field comprises a pressure field.
49. The method of claim 40 in which the field comprises an acoustic field.
50. The method of claim 1 in which the external influence comprises a reaction.
51. The method of claim 50 in which the reaction is chemical.
52. The method of claim 51 in which the chemical reaction is rotatory.
53. The method of claim 50 in which the reaction is molecular.
54. The method of claim 50 in which the reaction is cellular.
55. The method of claim 1 in which the external influence comprises a kinetic force.
56. The method of claim 55 in which the kinetic force is electroosmotic.
57. The method of claim 55 in which the kinetic force is based on electrophoretic.
58. The method of claim 55 in which the kinetic force is based on dielectrophoretic.
59. The method of claim 55 in which the kinetic force is based on optophoretic.
60. The method of claim 55 in which the kinetic force is based on thermophoretic.
61. The method of claim 1 in which the external influence comprises a gradient.
62. The method of claim 61 in which the gradient comprises a chemical gradient.
63. The method of claim 61 in which the gradient comprises a field gradient.
64. The method of claim 1 in which the other property comprises chirality.
65. The method of claim 1 in which one of the properties is imparted in the form of a dipole.
66. The method of claim 65 in which the dipole comprises an electric dipole.
67. The method of claim 65 in which the dipole comprises a magnetic dipole.
68. The method of claim 66 in which the external influence comprises a rotating electric field.
69. The method of claim 67 in which the external influence comprises a rotating magnetic field.
70. A method comprising
enhancing directional motion of a small object by applying an external influence to produce a force or torque acting on the object by operation of a first property that has been imparted to the object, the force or torque enhancing the directional motion of the object by operation of a second property that has been imparted to the object and includes responsiveness to the force or torque to cause the directional motion.
71. The method of claim 70 in which the small object is part of a first quantity of such small objects having both the first and second properties, and the quantity is mixed with a second quantity of other small objects that do not have both the first and second properties, and in which directional motion of the objects in the first quantity is enhanced relative to the second quantity of small objects.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09721269A EP2265714A4 (en) | 2008-03-21 | 2009-03-19 | Moving a small object in a direction |
| CN200980113998.3A CN102016021A (en) | 2008-03-21 | 2009-03-19 | Moving a small object in a direction |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3857308P | 2008-03-21 | 2008-03-21 | |
| US61/038,573 | 2008-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009117573A1 true WO2009117573A1 (en) | 2009-09-24 |
Family
ID=41089287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2009/037661 WO2009117573A1 (en) | 2008-03-21 | 2009-03-19 | Moving a small object in a direction |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20090239281A1 (en) |
| EP (1) | EP2265714A4 (en) |
| CN (1) | CN102016021A (en) |
| WO (1) | WO2009117573A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7935906B2 (en) | 2007-04-17 | 2011-05-03 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
| US8698031B2 (en) | 2007-04-17 | 2014-04-15 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011050153A1 (en) * | 2009-10-23 | 2011-04-28 | Dynamic Connections, Llc | Motion of a chiral object |
| CN106234487B (en) * | 2016-08-31 | 2021-05-14 | 周成录 | Drum-type dough kneading method and drum-type dough kneading machine |
| CN108593916A (en) * | 2018-04-08 | 2018-09-28 | 国家纳米科学中心 | Cancer detection system and method based on excretion body |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5752606A (en) * | 1996-05-23 | 1998-05-19 | Wilson; Steve D. | Method for trapping, manipulating, and separating cells and cellular components utilizing a particle trap |
| WO2007146675A2 (en) * | 2006-06-09 | 2007-12-21 | Dynamic Connections, Llc | Managing a chemical reaction and moving small particles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254258A (en) * | 1991-09-17 | 1993-10-19 | Research Corporation Technologies, Inc. | Chiral selector useful for separation of enantiomers of β-amino alcohol compounds |
| GB9301122D0 (en) * | 1993-01-21 | 1993-03-10 | Scient Generics Ltd | Method of analysis/separation |
| US6344121B1 (en) * | 1998-11-25 | 2002-02-05 | University Of Cincinnati | Preparative chiral separations |
| US6288206B1 (en) * | 1999-03-08 | 2001-09-11 | Molecular Optoelectronics Corporation | Chiral polymer compositions exhibiting nonlinear optical properties |
| AU2002334767B2 (en) * | 2001-10-01 | 2006-05-18 | Georgia Tech Research Corporation | High-throughput chiral detector and methods for using same |
| WO2004077038A2 (en) * | 2003-02-21 | 2004-09-10 | Duke University | Stationary phase for use in capillary electrophoresis, capillary electrochromatography, microfluidics, and related methods |
| AU2004288132A1 (en) * | 2003-08-12 | 2005-05-19 | Massachusetts Institute Of Technology | Sample preparation methods and devices |
| US20060073540A1 (en) * | 2004-06-04 | 2006-04-06 | La Corporation De L'ecole Polytechnique De Montreal | Method and system for controlling micro-objects or micro-particles |
| US8698031B2 (en) * | 2007-04-17 | 2014-04-15 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
| US7935906B2 (en) * | 2007-04-17 | 2011-05-03 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
-
2009
- 2009-03-19 CN CN200980113998.3A patent/CN102016021A/en active Pending
- 2009-03-19 US US12/407,380 patent/US20090239281A1/en not_active Abandoned
- 2009-03-19 WO PCT/US2009/037661 patent/WO2009117573A1/en active Application Filing
- 2009-03-19 EP EP09721269A patent/EP2265714A4/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5752606A (en) * | 1996-05-23 | 1998-05-19 | Wilson; Steve D. | Method for trapping, manipulating, and separating cells and cellular components utilizing a particle trap |
| WO2007146675A2 (en) * | 2006-06-09 | 2007-12-21 | Dynamic Connections, Llc | Managing a chemical reaction and moving small particles |
Non-Patent Citations (3)
| Title |
|---|
| FORSTER A.H. ET AL: "Use of moving optical gradient fields for analysis of apoptotic cellular responses in a chronic myeloid leukemia cell model", ANAL. BIOCHEM., vol. 327, no. 1, April 2004 (2004-04-01), pages 14 - 22, XP004495863 * |
| PAREDES G. ET AL: "Simulated moving bed chromatography: from chiral molecules to biocompounds", ANALYTICA WORLD, 2004, XP003025521 * |
| See also references of EP2265714A4 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7935906B2 (en) | 2007-04-17 | 2011-05-03 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
| US8698031B2 (en) | 2007-04-17 | 2014-04-15 | Dynamic Connections, Llc | Separation and manipulation of a chiral object |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2265714A1 (en) | 2010-12-29 |
| US20090239281A1 (en) | 2009-09-24 |
| EP2265714A4 (en) | 2011-09-28 |
| CN102016021A (en) | 2011-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Novák et al. | Protein extraction and precipitation | |
| Pereira et al. | Aqueous two-phase systems: Towards novel and more disruptive applications | |
| Benavides et al. | Extraction and purification of bioproducts and nanoparticles using aqueous two‐phase systems strategies | |
| Osaki et al. | Artificial cell membrane systems for biosensing applications | |
| Berensmeier | Magnetic particles for the separation and purification of nucleic acids | |
| Vuckovic et al. | Membrane proteomics by high performance liquid chromatography–tandem mass spectrometry: Analytical approaches and challenges | |
| CA2507592C (en) | Magnetism based rapid cell separation | |
| US20200024592A1 (en) | Highly active silica magnetic nanoparticles for purifying biomaterial and preparation method thereof | |
| US20090239281A1 (en) | Moving A Small Object in A Direction | |
| Chen et al. | Isolation/separation of plasmid DNA using hemoglobin modified magnetic nanocomposites as solid-phase adsorbent | |
| US11702648B2 (en) | Process for concentrating cells from a sample and then isolating nucleic acids from said cells | |
| CN104350152A (en) | Selective nucleic acid fragment recovery | |
| US9695216B2 (en) | Materials and methods for removing endotoxins from protein preparations | |
| Breyton et al. | Amphipols and fluorinated surfactants: two alternatives to detergents for studying membrane proteins in vitro | |
| Kim et al. | Rapid and efficient isolation of exosomes by clustering and scattering | |
| Chen et al. | Preparation of C60‐functionalized magnetic silica microspheres for the enrichment of low‐concentration peptides and proteins for MALDI‐TOF MS analysis | |
| CN103827135B (en) | There is the ion-exchange material of the high tolerance of salinity | |
| Dhadge et al. | An extracellular polymer at the interface of magnetic bioseparations | |
| US20100213136A1 (en) | Apparatus for moving magnetic particles | |
| Zhao et al. | Electro-Mechanical Conductance Modulation of a Nanopore Using a Removable Gate | |
| US20150093750A1 (en) | Magnetically assisted processing of a medium | |
| Zhang et al. | Improving isolation of extracellular vesicles by utilizing nanomaterials | |
| WO2003095646A1 (en) | Isolating nucleic acid | |
| EP2612864A1 (en) | Affinity tag system | |
| Takahashi et al. | DNA manipulation and single-molecule imaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 200980113998.3 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09721269 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009721269 Country of ref document: EP |